pentobarbital will decrease the level or outcome of atogepant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Advised atogepant dosage with concomitant usage of powerful or average CYP3A4 inducers is 30 mg or sixty mg qDay.pentobarbital will reduce the level or effect of stiripentol by affecting hepatic